Soybean as a Protein Biofactory Platform to Produce Epidermal Growth Hormone

Case ID:
UA17-206
Invention:

This invention is a soybean capable of producing Epidermal Growth Hormone as a therapeutic agent for a number of applications including reduction of necrotizing enterocolitis (NEC).

 

Background:
Necrotizing enterocolitis (NEC) is a dangerous condition that occurs in about 10% of premature infants. NEC often requires treatments like surgical removal of diseased and dead tissues. Epidermal growth factor (EGF), which is typically found in bodily fluids like amniotic fluid and breast milk, is known to help reduce the onset of NEC in premature infants. This invention provides a novel method to create human EGF through biological manipulation of soybeans.

 

Applications:

  • Necrotizing enterocolitis
  • Cosmetic skin agent
  • Sealing of intestinal walls
  • Healing of wounds and diabetic skin ulcers 


Advantages:

  • Bioactive
  • Comparable to commercially available human EGF

 
Status: issued U.S. patent #10,889,826

Patent Information:
Contact For More Information:
Tod McCauley
Assistant Director of Licensing, CALS
The University of Arizona
520-621-9493
todm@tla.arizona.edu
Lead Inventor(s):
Eliot Herman
Monica Schmidt
Brad Warner
Keywords: